These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 19259081)

  • 1. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of botulinum toxin in gastrointestinal disorders].
    Zepeda-Gómez S; Valdovinos-Díaz MA
    Rev Gastroenterol Mex; 2002; 67(2):126-33. PubMed ID: 12214336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
    Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
    J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin.
    Ciamarra P; Nurko S; Barksdale E; Fishman S; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):315-9. PubMed ID: 12960655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
    Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
    Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
    Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of internal anal sphincter achalasia with botulinum toxin.
    Messineo A; Codrich D; Monai M; Martellossi S; Ventura A
    Pediatr Surg Int; 2001 Sep; 17(7):521-3. PubMed ID: 11666049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
    Minkes RK; Langer JC
    J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
    Menteş BB; Irkörücü O; Akin M; Leventoğlu S; Tatlicioğlu E
    Dis Colon Rectum; 2003 Feb; 46(2):232-7. PubMed ID: 12576897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of posterior internal anal sphincter myectomy and intrasphincteric botulinum toxin injection for treatment of internal anal sphincter achalasia: a meta-analysis.
    Friedmacher F; Puri P
    Pediatr Surg Int; 2012 Aug; 28(8):765-71. PubMed ID: 22806601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of the use of botulinum toxin injection for functional anal pain.
    Hollingshead JR; Maeda Y; Brown TJ; Warusavitarne J; Vaizey CJ
    Colorectal Dis; 2011 Sep; 13(9):e293-6. PubMed ID: 21689353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blind randomized trial.
    Keshtgar AS; Ward HC; Sanei A; Clayden GS
    J Pediatr Surg; 2007 Apr; 42(4):672-80. PubMed ID: 17448764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.
    Schulte-Baukloh H; Knispel HH; Stolze T; Weiss C; Michael T; Miller K
    Urology; 2005 Oct; 66(4):865-70; discussion 870. PubMed ID: 16230156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term efficacy of fissurectomy and botulinum toxin injection for chronic anal fissure in females.
    Baraza W; Boereboom C; Shorthouse A; Brown S
    Dis Colon Rectum; 2008 Feb; 51(2):239-43. PubMed ID: 18175186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology and function of the internal anal sphincter after injection of botulinum toxin.
    Langer JC; Birnbaum EE; Schmidt RE
    J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano.
    Iswariah H; Stephens J; Rieger N; Rodda D; Hewett P
    ANZ J Surg; 2005 Jul; 75(7):553-5. PubMed ID: 15972045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defecation disorders in children after surgery for Hirschsprung disease.
    Chumpitazi BP; Nurko S
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):75-9. PubMed ID: 21694540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of individualized biofeedback training based on the underlying dysfunction for patients with imperforate anus.
    Zhengwei Y; Weilin W; Yuzuo B; Weisong C; Wei W
    J Pediatr Surg; 2005 Mar; 40(3):555-61. PubMed ID: 15793735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of excision of megarectum in children with anorectal malformation.
    Keshtgar AS; Ward HC; Richards C; Clayden GS
    J Pediatr Surg; 2007 Jan; 42(1):227-33. PubMed ID: 17208571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.